DOI: http://dx.doi.org/10.18203/issn.2456-3994.IntJMolImmunoOncol20164385

Using human medical waste to build biobanks

Jugnu Jain, Sreevatsa Natarajan, Soma Chatterjee

Abstract


India has a high disease burden and a large number of patients. There is a tremendous need for Indian biobanks to preserve Indian samples, to capture the great diversity of diseases to spur research into earlier, more precise diagnosis and better treatments for diseases plaguing India. This review article summarizes the key components of building a systematic comprehensive biobank, type and formats of sample and data, and the ethical and regulatory guidelines in India. An example of a growing Indian biobank, Sapien Biosciences, is shared along with its business model to reach sustainability. This is done by developing clinical diagnostics internally using the annotated samples but also sharing samples and outcomes data with external investigators. Our goal is to highlight the immense untapped value of Indian biospecimens and data, to catalyze the formation of collaborative networks of biobanks both within and outside India.

Keywords


Personalized medicine, Precision Diagnostics, Biorepository, Tissue bank, EMR, Outcomes Research

Full Text:

PDF

References


Park A. 8. Biobanks: 10 Ideas Changing the World Right Now. Time; 2009.

Baker M. Biorepositories: Building better biobanks. Nature 2012;486:141-6.

Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011;42:24-31.

Priyadarshini S. India Needs Gen-Next Cancer Biobank. Nature India; 2013. p. 103.

Saini KS, Saini ML, Marbaix E. Biobanking in the era of precision oncology. Indian J Med Paediatr Oncol 2015;36:1-2.

Available from: http://www.icmr.nic.in/ethical_guidelines.pdf. 2006.

Available at http://www.nabl-india.org/nabl/file_download. php?filename=201210170522-NABL-112-doc%20(1).pdf.

Sapien Partnership with Oncostem: Press Release; 2015. Available at http:// www.business-standard.com/article/companies/oncostem-ties-up-withsapien-for-breast-cancer-recurrence-diagnostic-test-115022300551_1.html.

Rath PC, Chidambaram S, Rath P, Dikshit B, Naik S, Sahoo PK et al. A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI. Indian Heart J 2015;67:114-21.




 
Home     |     Articles in Press     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     
       
       

International Journal of Molecular & ImmunoOncology, Quarterly, published by Medip Academy.     
Online ISSN: 2456-3994
This is an open-access journal, published articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.

website: www.ijmio.com   editorial contact: editor@ijmio.com

© Medip Academy. All Rights Reserved.